Znanstveni rad - Izvorni znanstveni rad
TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study
Microorganisms, 11 (2023), 6; 1571. https://doi.org/10.3390/microorganisms11061571

Šušak, Frano; Vrsaljko, Nina; Vince, Adriana; Papić, Neven

Citirajte ovaj rad

Šušak, F., Vrsaljko, N., Vince, A. i Papić, N. (2023). TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study. Microorganisms, 11. (6). doi: 10.3390/microorganisms11061571

Šušak, Frano, et al. "TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study." Microorganisms, vol. 11, br. 6, 2023. https://doi.org/10.3390/microorganisms11061571

Šušak, Frano, Nina Vrsaljko, Adriana Vince i Neven Papić. "TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study." Microorganisms 11, br. 6 (2023). https://doi.org/10.3390/microorganisms11061571

Šušak, F., et al. (2023) 'TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study', Microorganisms, 11(6). doi: 10.3390/microorganisms11061571

Šušak F, Vrsaljko N, Vince A, Papić N. TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study. Microorganisms [Internet]. 13.06.2023. [pristupljeno 29.05.2024.];11(6). doi: 10.3390/microorganisms11061571

F. Šušak, N. Vrsaljko, A. Vince i N. Papić, "TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD: A Prospective Case – Control Study", Microorganisms, vol. 11, br. 6, Lipanj 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:219307. [Citirano: 29.05.2024.]